European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Genetically modified allogeneic (human) tumour cells for the
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Genetically modified allogeneic (human) tumour cells for the expression of IL-7, GM-CSF, CD80 and CD154, in fixed combination with a DNA-based double stem loop immunomodulator (dSLIM)
| EU orphan designation number: | EU/3/06/405
|
| Active ingredient: | Genetically modified allogeneic (human) tumour cells for the expression of IL-7, GM-CSF, CD80 and CD154, in fixed combination with a DNA-based double stem loop immunomodulator (dSLIM) |
| Indication: | Treatment of renal cell carcinoma |
| Sponsor: | MOLOGEN AG
Fabeckstrasse 30, D-14195 Berlin, Deutschland |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 25/10/2006 | Centralised Orphan - Designation | EMEA/OD/021/06 | (2006)5152 of 23/10/2006 |